Acute hepatic cytolysis in an HIV-infected patient taking atazanavir

被引：8

作者：

Eholié, SP ^{[1
]}

Lacombe, K

Serfaty, L

Wendum, D

Girard, PM

机构：

[1] Hop St Antoine, Serv Malad Infect, F-75571 Paris, France

[2] Hop St Antoine, Serv Hepatol, F-75571 Paris, France

[3] Hop St Antoine, Serv Anat Pathol, F-75571 Paris, France

来源：

AIDS | 2004年 / 18卷 / 11期

关键词：

D O I：

10.1097/01.aids.0000131369.90575.9e

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1610 / 1611

页数：2

共 8 条

[1]

Arribas JR, 1998, AIDS, V12, P1722

[2] CAUSALITY ASSESSMENT OF ADVERSE REACTIONS TO DRUGS .2. AN ORIGINAL MODEL FOR VALIDATION OF DRUG CAUSALITY ASSESSMENT METHODS - CASE-REPORTS WITH POSITIVE RECHALLENGE [J].

BENICHOU, C ;

DANAN, G ;

FLAHAULT, A .

JOURNAL OF CLINICAL EPIDEMIOLOGY, 1993, 46 (11) :1331-1336

[3] Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor [J].

Carr, A ;

Cooper, DA .

LANCET, 1997, 349 (9057) :995-996

[4]

*NAT I ALL INF DIS, 1996, DIV AIDS TABL GRAD S

[5] Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human immunodeficiency virus-infected patients [J].

Savès, M ;

Raffi, F ;

Clevenbergh, P ;

Marchou, B ;

Waldner-Combernoux, A ;

Morlat, P ;

Le Moing, V ;

Rivière, C ;

Chêne, G ;

Leport, C .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (12) :3451-3455

[6] Indinavir-associated hepatitis in patients with advanced HIV infection [J].

Vergis, E ;

Paterson, DL ;

Singh, N .

INTERNATIONAL JOURNAL OF STD & AIDS, 1998, 9 (01) :53-53

[7]

Wang S, 2002, ANTIVIR THER, V7, pL6

[8] Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy [J].

Wit, FWNM ;

Weverling, GJ ;

Weel, J ;

Jurriaans, S ;

Lange, JMA .

JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (01) :23-31

← 1 →